Juvenescence Capitalizes BYOMass Inc. with up to $6.5 million
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Juvenescence Ltd, a biopharmaceutical company focused on treating aging and age-related disease, is pleased to announce its latest…
Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Juvenescence Ltd, a biopharmaceutical company focused on treating aging and age-related disease, is pleased to announce its latest…
BURTON-UPON-TRENT, England–(BUSINESS WIRE)–Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, announces that Foscavir (foscarnet sodium) has…
— More Than 35 Abstracts Across NASH, PSC and Viral Hepatitis Reflect Ongoing Commitment to Advancing Liver Disease Research and…
First DARZALEX combination regimen being pursued as frontline treatment option for transplant eligible patients with multiple myeloma BEERSE, Belgium–(BUSINESS WIRE)–The…
Leading industry analyst report into RIM cites AMPLEXOR Life Sciences as an example of a solution and services vendor that…
SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma”) (OTCQB: INNVD), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective…
DUBLIN–(BUSINESS WIRE)–The “Pain Therapeutics – Drugs, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…
DUBLIN–(BUSINESS WIRE)–The “Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose),…
New preclinical data to be presented on Core inhibitor EDP-514 targeting HBV FXR agonist EDP-305 targeting NASH ASK-1 inhibitors EP-026856…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together…